Lord Abbett Health Care F3 (LHCOX)
| Fund Assets | 8.67M |
| Expense Ratio | 0.68% |
| Min. Investment | $0.00 |
| Turnover | 91.00% |
| Dividend (ttm) | 0.08 |
| Dividend Yield | 0.34% |
| Dividend Growth | -23.43% |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 2, 2025 |
| Previous Close | 24.44 |
| YTD Return | 6.96% |
| 1-Year Return | 32.88% |
| 5-Year Return | 26.98% |
| 52-Week Low | 18.30 |
| 52-Week High | 24.71 |
| Beta (5Y) | n/a |
| Holdings | 60 |
| Inception Date | Jul 31, 2019 |
About LHCOX
Lord Abbett Health Care Fund Class F3 is a mutual fund focused on the health care sector, designed to achieve long-term capital appreciation by investing primarily in equity and equity-related securities of companies involved in health care and biotechnology. The fund typically allocates at least 80% of its assets to health care-related firms, covering industries such as pharmaceuticals, medical devices, health care services, and biotechnology. Its portfolio spans both U.S. and international companies, offering diversified exposure to the global health care market. With 58 holdings as of the latest data, the fund seeks to capture growth opportunities driven by innovation, demographic changes, and advancements in medical technology. The fund has a net expense ratio of 0.68% and does not require a minimum investment. Lord Abbett Health Care Fund Class F3 plays a specialized role in the market by providing investors targeted access to one of the most vital and dynamic sectors of the global economy, aligning with the MSCI ACWI Health Care Index as its benchmark.
Performance
LHCOX had a total return of 32.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.54%.
Top 10 Holdings
38.34% of assets| Name | Symbol | Weight |
|---|---|---|
| Eli Lilly and Company | LLY | 9.06% |
| AstraZeneca PLC | AZN | 4.82% |
| Gilead Sciences, Inc. | GILD | 4.33% |
| Johnson & Johnson | JNJ | 3.25% |
| Nektar Therapeutics | NKTR | 3.23% |
| Natera, Inc. | NTRA | 2.97% |
| Tarsus Pharmaceuticals, Inc. | TARS | 2.88% |
| Guardant Health, Inc. | GH | 2.68% |
| argenx SE | ARGX | 2.61% |
| Novartis AG | NOVN | 2.52% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 2, 2025 | $0.084 | Dec 2, 2025 |
| Nov 26, 2024 | $0.1097 | Nov 26, 2024 |
| Nov 22, 2022 | $0.0471 | Nov 22, 2022 |
| Nov 23, 2021 | $1.4724 | Nov 23, 2021 |
| Nov 24, 2020 | $2.3345 | Nov 24, 2020 |
| Nov 21, 2019 | $0.0104 | Nov 21, 2019 |